Our studies uncovered previously unidentified functions of csGRP78 in regulation of CD44 homeostasis, cell adhesion, and cell spreading, and our findings could have important therapeutic implications for blocking CD44v functions by targeting its partner protein in tamoxifen-resistant breast cancer. The gene discussed is CD44; the disease is breast carcinoma.